Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBMP-2 vs Autogenous Bone for Ridge Augmentation
NCT01541345Phase 3Completed
- Sponsor
- University of Zurich
- Start
- Feb 2011
- Primary completion
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of dibotermin alfa in tooth loss, sponsored by University of Zurich. Started Feb 2011; status: completed.
02
Drugs
dibotermin alfa
03
Conditions
tooth loss
Beyond the preview
Go deeper on NCT01541345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01541345.